2011 DOI: 10.1152/japplphysiol.00945.2010 PMID: 21030672 Read on PubMed Neural Regeneration Research Pentadecapeptide BPC 157 and the central nervous system Vukojevic J, Milavi M, Perovi D, et al
Semaglutide and nausea often go hand-in-hand
Typical candidates include: Individuals with a body mass index (BMI) 30 kg/m, or Individuals with a BMI 27 kg/m who also have at least one weight-related health condition such as hypertension, type 2 diabetes, or dyslipidemia Patients with a BMI below 27 are generally not eligible unless they have a separate FDA-approved indication (such as type 2 diabetes) and meet the medication's labeling
Damaged vial stoppers allow bacterial entry
Microdosing often means remaining at 0.25 to 1.0 mg long term
However, patients should note that discontinuing this medication can result in regaining lost weight